Target organ complications and prognostic significance of alerting reaction: Analysis from the Dallas Heart Study

Journal of Hypertension

Volumn 34, Issue 2, 2016, Pages 226-234

  Velasco, Alejandro ^a   Ayers, Colby ^a   Das, Sandeep R ^a   De Lemos, James A ^a   Khera, Amit ^a   Victor, Ronald G ^b   Kaplan, Norman M ^a   Vongpatanasin, Wanpen ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Blood pressure measurement; Cardiovascular events; Prognosis; Systemic hypertension; Target organ damage

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMIN TO CREATININE RATIO; ALCOHOL CONSUMPTION; ARTICLE; ATRIAL FIBRILLATION; BLOOD PRESSURE MEASUREMENT; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE MASS; HEART RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RENAL SYSTEM PARAMETERS; SMOKING; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ALBUMINURIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CORONARY DISEASE; HEART VENTRICLE; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY; RISK FACTOR; STROKE; URINE;

ADULT; ALBUMINURIA; ATRIAL FIBRILLATION; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; CORONARY DISEASE; CREATININE; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY; RISK FACTORS; STROKE;

EID: 84957431625     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000774     Document Type: Article

References (29)

1. Mancia G, Parati G, Pomidossi G, Grassi G, Casadei R, Zanchetti A. Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension 1987; 9:209-215.
2. Mo R, Omvik P, Lund-Johansen P. The Bergen Blood Pressure Study. Estimated prevalence of postural hypotension is influenced by the alerting reaction to blood pressure measurement. J Hum Hypertens 1994; 8:171-176.
3. Mejia AD, Egan BM, Schork NJ, Zweifler AJ. Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. Ann Intern Med 1990; 112:270-277.
4. Grassi G, Seravalle G, Buzzi S, Magni L, Brambilla G, Quarti-Trevano F, et al. Muscle and skin sympathetic nerve traffic during physician and nurse blood pressure measurement. J Hypertens 2013; 31:1131-1135.
5. Czarkowski M, Zajac K, Rozanowski K. Can the pressor response accompanying blood pressure measurement be limited in young, normotensive women? Blood Press Monit 2008; 13:1-5.
6. Wandstrat AE, Carr-Johnson F, Branch V, Gray H, Fairhurst AM, Reimold A, et al. Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J Autoimmun 2006; 27:153-160.
7. Victor RG, Haley RW, Willett DL, Peshock RM, Vaeth PC, Leonard D, et al. The Dallas Heart Study: A population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 2004; 93:1473-1480.
8. Jones CR, Taylor K, Poston L, Shennan AH. Validation of the Welch Allyn 'Vital Signs' oscillometric blood pressure monitor. J Hum Hypertens 2001; 15:191-195.
9. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010; 304:2503-2512.
10. Maroules CD, Khera A, Ayers C, Goel A, Peshock RM, Abbara S, King KS. Cardiovascular outcome associations among cardiovascular magnetic resonance measures of arterial stiffness: The Dallas heart study. J Cardiovasc Magnet Reson 2014; 16:33.
11. Kramer H, Toto R, Peshock R, Cooper R, Victor R. Association between chronic kidney disease and coronary artery calcification: The Dallas Heart Study. J Am Soc Nephrol 2005; 16:507-513.
12. Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS, et al. The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 2014; 30:485-501.
13. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005; 45:142-161.
14. Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, et al. Clinical practice guidelines for the management of hypertension in the community: A statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens 2014; 16:14-26.
15. Woodiwiss AJ, Molebatsi N, Maseko MJ, Libhaber E, Libhaber C, Majane OH, et al. Nurse-recorded auscultatory blood pressure at a single visit predicts target organ changes as well as ambulatory blood pressure. J Hypertens 2009; 27:287-297.
16. Muntner P, Levitan EB, Reynolds K, Mann DM, Tonelli M, Oparil S, Shimbo D. Within-visit variability of blood pressure and all-cause and cardiovascular mortality among US adults. J Clin Hypertens 2012; 14:165-171.
17. Abbas A, Szczepaniak LS, Tuncel M, McGavock JM, Huet B, Fadel PJ, et al. Adiposity-independent sympathetic activity in black men. J Appl Physiol 2010; 108:1613-1618.
18. Lambert EA, Rice T, Eikelis N, Straznicky NE, Lambert GW, Head GA, et al. Sympathetic activity and markers of cardiovascular risk in nondiabetic severely obese patients: The effect of the initial 10% weight loss. Am J Hypertens 2014; 27:1308-1315.
19. Seravalle G, Colombo M, Perego P, Giardini V, Volpe M, Dell'Oro R, et al. Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients. Hypertension 2014; 64:431-437.
20. Davy KP, Tanaka H, Andros EA, Gerber JG, Seals DR. Influence of age on arterial baroreflex inhibition of sympathetic nerve activity in healthy adult humans. Am J Physiol 1998; 275:H1768-H1772.
21. Limberg JK, Morgan BJ, Sebranek JJ, Proctor LT, Eldridge MW, Schrage WG. Neural control of blood flow during exercise in human metabolic syndrome. Exp Physiol 2014; 99:1191-1202.
22. Grassi G, Seravalle G, Quarti-Trevano F, Scopelliti F, Dell'Oro R, Bolla G, Mancia G. Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms. Hypertension 2007; 49:535-541.
23. Palatini P, Palomba D, Bertolo O, Minghetti R, Longo D, Sarlo M, Pessina AC. The white-coat effect is unrelated to the difference between clinic and daytime blood pressure and is associated with greater reactivity to public speaking. J Hypertens 2003; 21:545-553.
24. Grassi G, Turri C, Vailati S, Dell'Oro R, Mancia G. Muscle and skin sympathetic nerve traffic during the 'white-coat' effect. Circulation 1999; 100:222-225.
25. Lantelme P, Milon H, Vernet M, Gayet C. Difference between office and ambulatory blood pressure or real white coat effect: does it matter in terms of prognosis? J Hypertens 2000; 18:383-389.
26. Parati G, Ulian L, Santucciu C, Omboni S, Mancia G. Difference between clinic and daytime blood pressure is not a measure of the white coat effect. Hypertension 1998; 31:1185-1189.
27. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311:819-823.
28. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002; 105:1354-1359.
29. Mancia G, Grassi G. The autonomic nervous system and hypertension. Circ Res 2014; 114:1804-1814.